Abstract
Combined use of goserelin (zoladex) and anastrozole (arimidex) as second-line endocrine therapy in premenopausal women with advanced breast cancer — a study of its clinical and endocrine effects
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have